These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 1660638)

  • 21. Vaccination of pigs against pseudorabies with highly attenuated vaccinia (NYVAC) recombinant viruses.
    Brockmeier SL; Lager KM; Tartaglia J; Riviere M; Paoletti E; Mengeling WL
    Vet Microbiol; 1993 Dec; 38(1-2):41-58. PubMed ID: 8128602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-transmissible pseudorabies virus gp50 mutants: a new generation of safe live vaccines.
    Peeters B; Bouma A; de Bruin T; Moormann R; Gielkens A; Kimman T
    Vaccine; 1994 Mar; 12(4):375-80. PubMed ID: 8178562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of an intranasal immunization with gEgC and gEgI double-deletion mutants of Aujeszky's disease virus in maternally immune pigs and the effects of a successive intramuscular booster with commercial vaccines.
    Nauwynck HJ; Labarque GG; Pensaert MB
    Zentralbl Veterinarmed B; 1999 Dec; 46(10):713-22. PubMed ID: 10676150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oronasal challenge of fattening pigs after vaccination with an inactivated Aujeszky's disease vaccine.
    Pensaert MB; Vandeputte J; Andries K
    Res Vet Sci; 1982 Jan; 32(1):12-6. PubMed ID: 6283610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Air sampling procedure for evaluation of viral excretion level by vaccinated pigs infected with Aujeszky's disease (pseudorabies) virus.
    Bourgueil E; Hutet E; Cariolet R; Vannier P
    Res Vet Sci; 1992 Mar; 52(2):182-6. PubMed ID: 1316629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Trial of vaccination against Aujeszky's disease].
    Motovski A; Veselinova A; Dobrev V
    Vet Med Nauki; 1980; 17(5):32-7. PubMed ID: 6262995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of vaccination route on the efficacy of Aujeszky's disease deletion-mutant vaccine.
    Hasebe H; Osorio FA; Hogg A; Liauw H; Bartkoski MJ; Sugiyama M
    J Vet Med Sci; 1992 Aug; 54(4):693-8. PubMed ID: 1327180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the protective efficacy of Aujeszky's disease (pseudorabies) virus glycoproteins obtained from different sources.
    Puentes E; Eiras A; Cancio E; Nores MV; Aguilera A; Seoane R; Regueiro BJ
    Vet Microbiol; 1993 May; 35(1-2):45-59. PubMed ID: 8395745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aujeszky's disease vaccination and infection of pigs with maternal immunity: effects on cell- and antibody-mediated immunity.
    Wittmann G; Ohlinger V
    Arch Virol; 1987; 92(1-2):87-101. PubMed ID: 3026291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel concept for the control of Aujeszky's disease: experiences in two vaccinated pig herds.
    van Oirschot JT; Wijsmuller JM; de Waal CA; van Lith PM
    Vet Rec; 1990 Feb; 126(7):159-63. PubMed ID: 2155499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potency of an experimental DNA vaccine against Aujeszky's disease in pigs.
    Gerdts V; Jöns A; Mettenleiter TC
    Vet Microbiol; 1999 Mar; 66(1):1-13. PubMed ID: 10223318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination with recombinant vaccinia virus vaccines expressing glycoprotein genes of pseudorabies virus in the presence of maternal immunity.
    Brockmeier SL; Lager KM; Mengeling WL
    Vet Microbiol; 1997 Nov; 58(2-4):93-103. PubMed ID: 9453121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinction between Aujeszky's disease virus-infected and vaccinated pigs by hemagglutination-inhibition test.
    Shibata I; Uruno K; Samegai Y; Inaba Y
    J Vet Med Sci; 1993 Oct; 55(5):859-61. PubMed ID: 8286546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intranasal vaccination of pigs against Aujeszky's disease: comparison with inactivated vaccines in pigs with low maternal antibody titres.
    De Leeuw PW; Van Oirschot JT
    Res Vet Sci; 1985 Jul; 39(1):34-8. PubMed ID: 2994188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative efficacy of three doses of the genetically engineered Aujeszky's disease virus vaccine strain 783 in pigs with maternal antibodies.
    Kimman TG
    Vaccine; 1992; 10(6):363-5. PubMed ID: 1317982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental infection of fattening pigs with pseudorabies (Aujeszky's disease) virus: efficacy of attenuated live- and inactivated-virus vaccines in pigs with or without passive immunity.
    Vannier P
    Am J Vet Res; 1985 Jul; 46(7):1498-502. PubMed ID: 2992327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of vaccine medium and vaccination schedules on the induction of active immunity against Aujeszky's disease in maternally immune pigs.
    De Smet K; De Waele K; Pensaert M
    Res Vet Sci; 1994 Jan; 56(1):89-94. PubMed ID: 8146460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extent and duration of virulent virus excretion upon challenge of pigs vaccinated with different glycoprotein-deleted Aujeszky's disease vaccines.
    Pensaert MB; De Smet K; De Waele K
    Vet Microbiol; 1990 Apr; 22(2-3):107-17. PubMed ID: 2162094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection of pigs against Aujeszky's disease by DNA vaccination.
    Gerdts V; Jöns A; Makoschey B; Visser N; Mettenleiter TC
    J Gen Virol; 1997 Sep; 78 ( Pt 9)():2139-46. PubMed ID: 9291999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Virus-neutralizing antibodies in the colostrum and milk of brood sows vaccinated with an ethanol vaccine against Aujeszky's disease virus].
    Diakov I
    Vet Med Nauki; 1977; 14(8):82-6. PubMed ID: 204104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.